Truist reiterates Buy on Affirm stock, lowers price target to $86

Truist reiterated a Buy rating on Affirm (AFRM) but lowered its price target to $86 from $88, citing lower fintech multiples. AFRM trades at $62.71, with Truist estimating 35% Q2 FY2027 GMV growth. Truist also adjusted EPS estimates, noting lower margins. Analysts have mixed views, with some raising targets and others lowering them due to credit concerns.

Original reporting
Published Nov 17, 2026, 11:18 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 17, 2026, 11:29 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$AFRM
Neutral
medium confidence
Mentioned
$AFRM
Relevance
4/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$AFRMNeutralLow
01

Why it matters

The main tradable input is the revised valuation framework (lower multiples) and the direction of estimate changes (higher GMV, lower margins/EPS, modestly lower take-rate expectations).

02

Market read

Provides a near-term sentiment and valuation reference point for AFRM, but it is not a new earnings or guidance release from the company.

03

What to watch

The note attributes changes to funding costs and credit provisions assumptions; traders may want to monitor whether actual credit performance and take-rate trends confirm or contradict these refreshed assumptions.

Relevance 4/10Novelty 4/10Timing: pre-market/near-term sentiment impact from the analyst note

Background

The piece summarizes Truist Securities’ updated model for Affirm, including GMV growth, RLTC take rate expectations, and GAAP EPS changes, alongside other recent analyst target revisions.

Company-level read

Ticker impact

$AFRMNeutralMedium confidence
Context

Truist reiterated a Buy on Affirm and cut its price target to $86, citing lower fintech-lender target multiples and updated GMV/EPS assumptions.

Expected impact

Likely mild upside bias from the reiterated Buy, partially offset by the reduced price target and the note of lower margins and funding/credit assumptions.

Evidence & confidence

The article is an analyst note with a specific target cut and updated estimates (GMV growth, RLTC take rate, GAAP EPS), which can influence near-term sentiment but is not a new company disclosure.

Market effects

Highlights that fintech-lender valuation multiples have declined as investors weigh macro credit and regulatory risk, which can pressure the peer group’s multiples.

No specific regional market catalyst beyond US-listed fintech sentiment.

Limited, as the driver is US analyst valuation framing around credit/regulatory risk.

Counterpoint

The target cut and lower GAAP EPS estimate could signal that downside risks (margins, credit provisions) are being underappreciated, even if GMV growth expectations were raised.

Key entities

  • Affirm Holdings

    Subject of the analyst reiteration and price-target cut, with updated GMV, take-rate, and EPS assumptions.

  • Truist Securities

    Reiterated Buy and lowered the price target to $86, citing lower fintech-lender multiples and updated estimate drivers.

Related articles

$AFRMMed

Levchin Says Affirm Is Moving With “Deliberate Aggression.” Ratepay Takes It Into Germany in 2027

Affirm (AFRM) agreed to acquire Ratepay, a German pay-by-invoice provider, from Nexi (NEXI), with the deal expected to close in the first half of 2027. Affirm's revenue rose 35% to $1.26 billion, but credit losses increased 59%. The company's international expansion is minimal, with Europe contributing little to growth. Affirm has $3.0 billion in liquidity and plans to add installment loans in Germany.

$AFRMMed

Mizuho reiterates Affirm stock rating on path to 2030 earnings goal

Mizuho reiterated an Outperform rating and $100 price target for Affirm (AFRM), citing Q1 fiscal 2027 results supporting its 2030 earnings goal. AFRM stock is down 2.61% in the past week, trading at $67.84. Gross merchandise volume grew 34% to $14.4 billion, and revenue rose 32.69% to $4.59 billion. Analysts have mixed reactions to AFRM's performance and future prospects.

$AFRMMed

Chime and Affirm Show the Trade-Offs Behind Credit Growth

Chime and Affirm are expanding credit offerings. Chime's Prime members can access credit lines with $3,000 monthly deposits, while Affirm's debit card extends installment loans to non-partner retailers. Chime reported higher losses due to increased borrowing, with first-time borrowers driving losses. Affirm's card transactions are mostly interest-bearing, with plans to introduce card-specific financing offers.

$AFRMMedAI 8/10

Affirm and Nuvei Seek Bigger Roles in Payment Operations

Affirm agreed to acquire Ratepay, a German payments company, expanding its merchant network in Germany, Austria, and Switzerland. The deal is expected to close in 2027. Nuvei announced a $2.75B acquisition of Payoneer, adding cross-border payout and multi-currency services. Payoneer's Q3 earnings showed growth in enterprise payouts and B2B volume. Both deals aim to enhance embedded finance capabilities for merchants.

$UPSTHigh

Upstart Sinks 11% as Hot Inflation Report Hits Fintech Lenders; SoFi Falls 4%, Affirm Slides 3%

Upstart Holdings (UPST) fell 11% to $19.87 after a hot inflation report increased expectations of a Fed rate hike, impacting its rate-sensitive business. The company revised its 2026 revenue and EBITDA guidance downward, citing macroeconomic headwinds. SoFi (SOFI) and Affirm (AFRM) also declined but less sharply, as their funding models are less sensitive to rate changes. Analysts lowered UPST's EPS estimates, with a consensus price target of $31.19.